World Aids Day
The global challenge of HIV/AIDS remains one of the most pressing public health issues today. According to the latest data from UNAIDS, around 38.4 million people worldwide are living with HIV/AIDS, underlining the need for not only medical intervention but also comprehensive awareness, education, and social change. Despite the significant strides made in treatment and prevention, the confusion surrounding the relationship between HIV and AIDS still persists.
Young people have become influential advocates in the fight against HIV/AIDS. Research from UNICEF shows that youth-led initiatives can lower HIV transmission rates by as much as 45% in targeted communities. These young activists utilize digital platforms and peer-to-peer education to dispel myths, promote safe practices, and foster supportive environments for those affected by HIV/AIDS.
Dr Gowri Kulkarni, an expert in Internal Medicine, explains that while the terms HIV and AIDS are often used interchangeably, they are distinctly different. "HIV (Human Immunodeficiency Virus) is a virus that attacks the immune system, whereas AIDS (Acquired Immunodeficiency Syndrome) is a condition that occurs when HIV severely damages the immune system," she clarifies. To understand the implications of these differences, it's important to explore the fundamental distinctions between the two.
HIV is the virus responsible for attacking the body’s immune system, specifically targeting CD4 cells, which are crucial for the body’s defense against infections. As HIV progresses, it destroys these cells, weakening the immune system over time. If left untreated, this continuous damage can lead to AIDS.
AIDS, on the other hand, is a syndrome, not a virus. Dr Kulkarni further elaborates that AIDS is a collection of symptoms and illnesses that emerge when the immune system is severely compromised due to prolonged HIV infection. It represents the most advanced stage of HIV, and is characterized by very low CD4 counts or the onset of opportunistic infections like tuberculosis, pneumonia, or certain cancers.
A key distinction to remember is that not everyone with HIV will progress to AIDS. Thanks to advancements in medicine, particularly antiretroviral therapy (ART), individuals living with HIV can manage the virus and maintain a healthy immune system for many years, or even decades, without ever developing AIDS. ART works by suppressing the virus to undetectable levels, effectively preventing the damage HIV would otherwise cause to the immune system.
Without treatment, however, HIV progresses through three stages:
- Acute HIV Infection: This stage occurs shortly after transmission and may include symptoms like fever, fatigue, and swollen lymph nodes.
- Chronic HIV Infection: Often asymptomatic or mildly symptomatic, the virus continues to damage the immune system but at a slower rate.
- AIDS: This is the final stage, marked by severe immune damage and the presence of infections that take advantage of the compromised immune defenses.
Another key distinction between HIV and AIDS is the way in which they are transmitted. HIV is highly contagious and can be transmitted through the exchange of bodily fluids such as blood, semen, vaginal fluids, and breast milk. It is primarily spread through unprotected sexual contact, sharing needles, or from mother to child during childbirth or breastfeeding.
AIDS, however, is not transmissible. It is not a disease that can be passed from one person to another. Rather, AIDS is the result of untreated, advanced HIV infection and is a direct consequence of the virus’s damage to the immune system.
HIV and AIDS are diagnosed through different methods. HIV is diagnosed through blood tests or oral swabs that detect the presence of the virus or antibodies produced by the immune system in response to the virus. Early detection of HIV is crucial, as it allows for timely intervention and treatment, which can prevent the virus from progressing to AIDS.
AIDS, on the other hand, is diagnosed using more specific criteria. Dr Kulkarni notes that the diagnosis of AIDS is made when the individual’s CD4 cell count falls below 200 cells/mm³, or when opportunistic infections or certain cancers (such as Kaposi's sarcoma or lymphoma) are detected. Diagnosing AIDS involves a more thorough assessment of the individual’s immune function and overall health, as opposed to just the detection of HIV.
The treatment goals for HIV and AIDS differ significantly, although both involve antiretroviral therapy (ART). For HIV, the primary treatment goal is to suppress the virus to undetectable levels, thus maintaining a strong immune system and preventing further transmission of the virus. People living with HIV can often live long, healthy lives if they adhere to ART.
For individuals diagnosed with AIDS, the treatment plan becomes more complex. While ART remains an essential part of managing the virus, treatment for AIDS also focuses on addressing the opportunistic infections and secondary health complications associated with severe immune suppression. The goal of treatment for AIDS is not only to manage the HIV virus but also to improve the quality of life and extend survival by treating these secondary health issues.
While the medical community has made great strides in managing HIV, the battle to curb its transmission is also a social and cultural issue. Dr Daman Ahuja, a public health expert, highlights that HIV/AIDS awareness and education are vital to reducing transmission rates and supporting those affected by the virus. "Young people, especially, have become key advocates in the fight against HIV/AIDS," says Dr Ahuja. "Research from UNICEF shows that youth-led initiatives can lower HIV transmission rates by as much as 45% in targeted communities."
Additionally, grassroots activism plays a significant role in raising awareness and addressing stigma. As the World Health Organization reports, community-based interventions have been proven to increase HIV testing rates and improve treatment adherence, which are crucial in the fight against the pandemic.
The ultimate goal of organizations like UNAIDS is to eliminate the HIV/AIDS pandemic by 2030. Achieving this requires global collaboration, from medical treatment advancements to public health strategies, education, and advocacy. Dr Kulkarni’s insight underscores the importance of early detection, treatment adherence, and community support in the fight against HIV/AIDS.
Dr Gowri Kulkarni is Head of Medical Operations at MediBuddy and Dr Daman Ahuja, a public health expert and has been associated with Red Ribbon Express Project of NACO between 2007-12.
Credit: iStock
Amid reports of the hantavirus outbreak onboard the cruise ship MV Hondius, and two Indian crew members, India’s Ministry of Health and Family Welfare has stepped up surveillance measures.
While the Indian Embassy in Spain has confirmed that the two Indian nationals are currently asymptomatic and are being evacuated to the Netherlands for quarantine, health authorities in the country are closely monitoring the situation in coordination with national and international health agencies.
Notably, the Indian Council of Medical Research (ICMR) has mobilized its formidable "Viral Shield", a sophisticated network of 165 specialized laboratories, called the Virus Research & Diagnostic Laboratory (VRDL), to ensure that the rat-borne virus does not breach the country's borders.
The 165 laboratories include
Post-pandemic, VRDLs are actively engaged in integrated surveillance for Influenza-like Illness (ILI) and Severe Acute Respiratory Infection (SARI), monitoring for pathogens like Influenza A/B, Mycoplasma pneumonia, and SARS-CoV-2 variants.
In 2025, Union Minister of State for Health and Family Welfare, Anupriya Patel, said, VRDL has stood as “sentinels in protecting the country”.
She added that 16 VRDLs are now equipped with Bio-Safety Level-3 (BSL-3) facilities for studying high-risk pathogens, playing a central role in detecting outbreaks of Nipah, Zika, and Kyasanur Forest Disease.
Also read: Hantavirus: Is Climate Change Behind The Outbreak?
Amid stiff opposition from the locals, the Dutch-flagged vessel MV Hondius, carrying 94 people, including Filipinos, Britons, Americans, Indians, and Spaniards, arrived in Spain's Canary Islands on May 10. All have been evacuated and repatriated.
Two of the 17 American passengers evacuated from the hantavirus-hit MV Hondius have tested positive, the US Department of Health and Human Services (HHS) announced today.
A French woman onboard the same cruise has also tested positive for hantavirus, and her health worsened in the hospital overnight, French Health Minister Stephanie Rist said.
The woman was among five French passengers repatriated from the MV Hondius.
"It’s not surprising that others on the ship will test positive for hantavirus in the coming days. What’s crucial is that they don’t pass this on to others- those most at risk: who they live with/family/friends as they head home. Quarantine for next 45 days super important," Prof. Devi Sridhar, Professor & Chair of Global Public Health, Edinburgh University, said in a post on the social media platform X.
Read More: Why The Norovirus Outbreak On A Caribbean Cruise Ship Is Not A Cause for Panic
The WHO maintains that the eight passengers on board have been infected with hantavirus. While three have died, six have been hantavirus infection has been confirmed in six cases.
Dr. Maria Van Kerkhove, the WHO’s head of epidemic and pandemic preparedness, said that after being brought to shore, passengers will be kept cordoned off from the public and taken to repatriation flights.
In their home countries, many will be taken onward to isolation facilities. Van Kerkhove said that the WHO is recommending “active monitoring and follow-up” for all passengers and crew for 42 days from their “last point of exposure” to a confirmed case.
"Our recommendation is daily health checks, at home or in a specialized facility. It's up to countries to develop their policies, but our recommendations are very clear," Van Kerkhove said, highlighting that the incubation period for the virus was up to six weeks.
Credit: iStock
In my journey as a neonatologist, one truth has remained constant—no healthcare system can succeed without strong nursing care. We often celebrate breakthroughs in technology and clinical expertise, but at the bedside, where outcomes are truly shaped, it is the nurse who makes the difference.
Nowhere is this more evident than in the Neonatal Intensive Care Unit (NICU), a space I have spent decades working in. Caring for extremely premature babies—sometimes born as early as 24–26 weeks—requires far more than advanced machines or protocols. These fragile lives demand minute-to-minute monitoring, swift clinical judgment, and unwavering attention.
It is the nurse who notices the subtle drop in oxygen levels, the slight change in skin tone, or the early signs of infection. Many times, it is their timely intervention that prevents a complication from becoming a crisis. I have witnessed countless such moments—quiet, uncelebrated, yet life-saving.
What we see in practice is strongly supported by global data. Research has consistently shown that for every additional patient assigned to a nurse, the risk of patient mortality increases by nearly 7%. Hospitals with optimal nurse-to-patient ratios report lower infection rates, shorter hospital stays, and significantly better survival outcomes. These are not marginal gains—they are decisive factors in patient care.
And yet, as healthcare advances, a critical gap is becoming increasingly visible.
Over the past five to six decades, medicine has transformed dramatically. We have moved from general practice to highly specialized and super-specialized care—interventional cardiology, robotic surgeries, advanced oncology, and neonatal care that can support extremely preterm infants. These advancements have contributed to a remarkable rise in life expectancy in India—from around 41 years in the 1960s to over 69 years today.
But while medicine has rapidly specialized, nursing training has not evolved at the same pace. This imbalance is one of the most pressing challenges in healthcare today.
India, like many parts of the world, faces a significant workforce gap. The World Health Organization estimates a global shortage of nearly 6 million nurses. While we continue to train and recruit more nurses, the real challenge lies in specialized skill development. In many hospitals, nurses are assigned to departments based on immediate needs rather than structured career pathways. They learn on the job, often in high-pressure environments, building expertise through experience.
While this speaks volumes about their dedication and resilience, it also highlights a systemic limitation. Specialized medicine cannot function optimally without specialized nursing.
In a NICU, for instance, managing non-invasive ventilation, performing neonatal resuscitation, ensuring strict infection control, and counselling anxious parents are not basic skills—they are specialized competencies. These require structured training, repeated practice, and continuous upskilling.
Recognizing this gap, we recently conducted 10 focused workshops across Karnataka as part of the State Neonatal Nurses Conference. These workshops were designed to strengthen critical skills such as the Neonatal Resuscitation Program (NRP), Non-Invasive Ventilation (NIV), and effective communication within the NICU. What stood out was the response.
Participation exceeded capacity by nearly four times. Nurses travelled long distances, eager to learn, engage, and enhance their skills. This was not just enthusiasm—it was intent. It was a clear indication that nurses are ready to grow, to specialize, and to deliver better outcomes. What they need is access—structured, scalable, and sustained opportunities to learn.
Globally, the impact of investing in nursing education is well documented. Hospitals with a higher proportion of well-trained nurses have reported up to 20% lower mortality rates in certain patient groups. Healthcare systems that prioritize continuous professional development for nurses consistently demonstrate better patient safety outcomes and higher satisfaction levels.
India has begun to take steps in this direction. Initiatives such as the Neonatal Nurse Fellowship introduced by the National Neonatology Forum are important milestones. However, these programs, while valuable, are not accessible to all. Financial constraints, time commitments, and geographical limitations often restrict participation.
This calls for a shift in approach.
Training must move beyond select programs and become an integral part of the healthcare system. We need modular learning formats, simulation-based training, in-hospital skill development programs, and digital platforms that allow continuous learning. Every nurse—irrespective of location or institution—should have access to opportunities that help them grow.
Because ultimately, no matter how advanced our systems become, outcomes depend on the people delivering care.
I often remind my teams of a simple reality—without strong nursing care, the success of any medical speciality is less than 50%.
Beyond systems, statistics, and strategy lies the human side of nursing—a dimension that cannot be measured but is deeply felt.
In the NICU, nurses are not just caregivers to fragile newborns; they are also a source of strength for parents navigating uncertainty and fear. I have seen nurses hold the hands of anxious mothers, explain complex medical situations with patience, and provide reassurance during some of the most difficult moments a family can experience. They are the bridge between clinical excellence and emotional care.
And yet, despite their central role, nurses often remain under-recognized and under-supported. If we are serious about strengthening healthcare, this must change.
Empowering nurses is not just about improving skills—it is about acknowledging their value, creating structured career pathways, and ensuring they are included in decision-making processes. It is about building a culture of respect, where nursing is seen not as support, but as a critical pillar of care delivery.
The future of healthcare will not be defined by technology alone. It will be defined by the strength, capability, and empowerment of its workforce.
And at the heart of that workforce are our nurses. If we want safer hospitals, better clinical outcomes, and resilient healthcare systems, the path forward is clear—we must invest in our nurses, not just in numbers, but in their growth, training, and empowerment. Because in every critical moment I have witnessed, one truth stands out—quietly, consistently, and powerfully: Empowered nurses don’t just support care. Empowered nurses save lives.
Dr. R. Kishore Kumar is President – National Neonatology Forum, Karnataka Chapter
Credit: AI generated image
Post-viral syndromes are a classic example of the body not feeling better even after the viraemia is over. When a viral infection ends, most people expect life to quickly return to normal.
For many, it does, but for some, recovery stretches on for weeks or even months. This condition, often called a post-viral syndrome, is now being seen more clearly across the country, especially after the COVID-19 pandemic. Thus, the main question that arises is why doesn’t recovery end when the infection is gone? The answer is that the body does not always ‘reset’ immediately.
During an infection, the body’s defense system becomes highly active to fight the virus. In some people, this response does not completely settle down even after the virus has been cleared. This can lead to ongoing tiredness, body aches, or a general feeling of being unwell. This could be due to the immune system remaining partially activated.
In certain cases, the body’s defense system may even start reacting in an unbalanced way, affecting normal tissues. This is why some people develop symptoms like joint pains, palpitations, or dizziness after a viral illness, even though tests may not show an active infection.
Another important reason is energy depletion. Viral infections can temporarily affect how the body produces and uses energy. As a result, even small physical or mental efforts can feel exhausting. Many patients describe a pattern where they feel better, try to return to normal activity, and then feel worse again. This cycle can delay full recovery. The nervous system can also be affected. Some people experience what is commonly called ‘brain fog’, poor sleep, or a sense of imbalance in heart rate and blood pressure. These symptoms are real and are part of the body’s recovery process.
Also, there is something called POT (Positional Orthostatic Tachycardia) syndrome. Patients, when they get up and stand, develop mild giddiness and palpitations.
It is also important to understand that the body may take time to rebuild strength. Muscle loss, physical inactivity, and lack of appetite are common effects following an illness.
Consequently, when an individual has recovered from the virus, it is more than just getting rid of the virus. It involves restoring and getting stronger over time. Most importantly, recovery should never be rushed. Pushing too hard or returning to high levels of activity too soon after becoming ill can lead to worsening of symptoms and therefore prolong the recovery time.
A more effective way to recover is by taking a gradual, steady approach. Recovery involves resting adequately, maintaining a nutritious diet, engaging in light exercise and receiving adequate amounts of sleep and at the same time being aware of how your body feels. Long-term symptoms are not in your head. They are part of the process of healing that occurs after some forms of infection.
Most people will recover, but patience and using proper methods are key to recovering completely. It is also important to understand that recovery involves rebuilding the strength that the body needs time to restore this balance.
It is important not to get carried away assuming post-viral syndrome, but consult a physician and not miss out on an underlying medical disorder, and investigate appropriately.
© 2024 Bennett, Coleman & Company Limited